IRNA LOMANA
MIAMI, FL
Browse related groups: FL PFIZER INC. All categories
This page merges CMS profile IDs: 11551955, 11613125 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$538.10
- Category: General Payments
- Program years: PY2022–2024
- Record count: 9
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $339.08 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $339.08 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $124.91 | 1 |
| Regeneron Healthcare Solutions, Inc. | $121.81 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $53.73 | 3 |
| Astellas Pharma US Inc | $23.11 | 1 |
| Janssen Biotech, Inc. | $15.52 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078443668 | Janssen Biotech, Inc. | $15.52 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087148190 | Novartis Pharmaceuticals Corporation | $20.92 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087148192 | Novartis Pharmaceuticals Corporation | $13.57 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087148200 | Novartis Pharmaceuticals Corporation | $19.24 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114333891 | Regeneron Healthcare Solutions, Inc. | $121.81 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131915183 | PFIZER INC. | $124.91 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139560827 | Astellas Pharma US Inc | $23.11 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 11551955, 11613125
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.